Document Detail

Subintimal angioplasty for infrainguinal occlusive disease.
MedLine Citation:
PMID:  15364560     Owner:  NLM     Status:  MEDLINE    
Subintimal angioplasty is a relatively new endovascular approach for the treatment of patients with femoropoliteal or tibial artery occlusion. The procedure involves intentionally creating a false channel or dissection around an arterial occlusion, then reentering the true lumen distally. The procedure has a relatively low incidence of complications and a high rate of technical success.Short-term patency has been fair in some reports and poor in others. Long-term results are not available. Aspirin and possibly anticoagulation or antiplatelet agents may improve technical success and short-term patency. Further studies with longer follow-up are required before it can be recommended as a potentially viable alternative to arterial bypass.
Gerald S Treiman
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Surgical clinics of North America     Volume:  84     ISSN:  0039-6109     ISO Abbreviation:  Surg. Clin. North Am.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-09-14     Completed Date:  2004-11-09     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0074243     Medline TA:  Surg Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1365-80, viii     Citation Subset:  AIM; IM    
Veterans Affairs, Salt Lake City Health Care System, Surgical Care Center (112), 500 Foothill Drive, Salt Lake City, UT 84148, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Angioplasty, Balloon / methods*
Arterial Occlusive Diseases / surgery*
Lower Extremity / blood supply
Middle Aged

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Current endovascular management of atherosclerotic renal artery stenosis.
Next Document:  Endovascular management of iliofemoral venous occlusive disease.